Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase
Authors:
- 5 January 2010
- journal article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 31 (1) , 93-101
Abstract
Aim: Methods: Results: Conclusion:Keywords
This publication has 39 references indexed in Scilit:
- Histone deacetylase inhibitors in cancer therapyCurrent Opinion in Oncology, 2008
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008
- Sodium butyrate-induced death-associated protein kinase expression promote Raji cell morphological change and apoptosis by reducing FAK protein levelsActa Pharmacologica Sinica, 2007
- Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxelAnti-Cancer Drugs, 2007
- Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cellsInternational Journal of Cancer, 2007
- Adjuvant Chemotherapy for Non-small Cell Lung CancerJournal of Thoracic Oncology, 2007
- Cancer epigenomics: DNA methylomes and histone-modification mapsNature Reviews Genetics, 2007
- The Epigenomics of CancerCell, 2007
- Control of Death-associated Protein Kinase (DAPK) Activity by Phosphorylation and Proteasomal DegradationJournal of Biological Chemistry, 2006
- DAP-kinase Participates in TNF-alpha and Fas-induced Apoptosis and Its Function Requires the Death DomainJournal of Cell Biology, 1999